MedTrace Logo

Shoulder Corticosteroid Injection in Diabetic Patients

NCT03652480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-08-31

No results posted yet for this study

Summary

In type 2 diabetic patients affected by chronic shoulder pain, subacromial injection with corticosteroid could be an effective treatment. The aim of this study was to measure the risk-benefit ratio of this treatment.Twenty patients with well-controlled diabetes were included in a prospective study. In a first pre-injection phase, patients were asked to measure glycemia for 7 days, before breakfast and dinner, then 2 hours after lunch and dinner. Baseline data including Constant Score (CS), Subjective Shoulder Value (SSV) and Numerical Rating Scale (NRS) for pain were collected. Patients were treated with subacromial injection with 40mg of Methylprednisolone Acetate and 2ml of Lidocaine. At discharge, patients were asked to re-measured glycemia for the following week.

Conditions

  • Shoulder Pain
  • Corticosteroid Injection
  • Type2 Diabetes Mellitus

Interventions

DRUG

MethylPREDNISolone Acetate 40 MG/ML

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-03-31
Completion
2014-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03652480 on ClinicalTrials.gov